This finding is consistent with previous reports suggesting that less than half of carriers identified through population genetic testing meet current clinical testing criteria.17 The significance of accurate variant interpretation, particularly in individuals who do not meet phenotype-based criteria, was highlighted by case 3 who was referred for clinical testing on the basis of the miscalled inversion in TSC2 and LOH in their tumor. Here, TSC2 is linked to neoplasm.